![](\"http:\/\/www.erzurumflas.com\/wp-content\/uploads\/2020\/12\/prostat-kanseri-erkeklerde-en-sik-gorulen-ikinci-kanser-turu_184ad8f.jpg\")
D\u00fcnyada ve T\u00fcrkiye\u2019de erkeklerde en s\u0131k g\u00f6r\u00fclen kanser t\u00fcrlerinden olan prostat kanseri, erkeklerde kansere ba\u011fl\u0131 \u00f6l\u00fcmlerde de akci\u011fer kanserinin ard\u0131ndan ikinci s\u0131rada yer al\u0131yor. 2018 y\u0131l\u0131 istatistiklerine g\u00f6re, d\u00fcnya genelinde 1,28 milyon hasta prostat kanseri tan\u0131s\u0131 alm\u0131\u015f bulunuyor.<\/p>\n
T\u00fcrk \u00dcroonkoloji Derne\u011fi taraf\u0131ndan haz\u0131rlanan \u201cT\u00fcrkiye Prostat Kanseri Haritas\u0131\u201dn\u0131n sonu\u00e7lar\u0131na g\u00f6re, prostat kanseri, hastalar\u0131n yar\u0131s\u0131nda 60-69 ya\u015f aral\u0131\u011f\u0131nda g\u00f6r\u00fcl\u00fcrken, d\u00fczenli kontrollere dair fark\u0131ndal\u0131\u011f\u0131n artmas\u0131yla ge\u00e7mi\u015f y\u0131llara oranla daha erken a\u015famalarda tespit ediliyor.<\/p>\n
T\u00fcrk \u00dcroonkoloji Derne\u011fi Y\u00f6netim Kurulu Ba\u015fkan\u0131 Prof. Dr. S\u00fcleyman Ataus, \u201cS\u0131k idrara gitme, idrar yaparken zorlanma ve idrarda kan g\u00f6r\u00fclmesi gibi \u00fcrolojik \u015fikayetlerin yakla\u015f\u0131k yar\u0131s\u0131nda prostat kanseri saptan\u0131yor. Yine derne\u011fimiz taraf\u0131ndan 2009 y\u0131l\u0131nda yap\u0131lan \u00e7al\u0131\u015fmada bu oran y\u00fczde 90\u2019a yak\u0131nd\u0131. Bu oran\u0131n azalmas\u0131nda prostat kanserine y\u00f6nelik toplumsal bilincin artmas\u0131n\u0131n etkili oldu\u011funu d\u00fc\u015f\u00fcn\u00fcyoruz. Bununla birlikte mevcut oran da, belirtilerin \u00e7e\u015fitlili\u011fi kar\u015f\u0131s\u0131nda prostat kanserine y\u00f6nelik d\u00fczenli kontrollerin \u00f6nemini ortaya koyuyor. Haz\u0131rlad\u0131\u011f\u0131m\u0131z rapor \u00fclkemizde prostat kanseri fark\u0131ndal\u0131\u011f\u0131n\u0131n art\u0131r\u0131lmas\u0131n\u0131, bu konular\u0131n bilimsel alanlarda tart\u0131\u015f\u0131lmas\u0131n\u0131n sa\u011flanmas\u0131n\u0131 ama\u00e7l\u0131yor” diye konu\u015ftu.<\/p>\n
Tan\u0131 an\u0131nda metastatik kanserin saptanma s\u0131kl\u0131\u011f\u0131 son 10 y\u0131lda yar\u0131 yar\u0131ya azald\u0131<\/p>\n
Raporda, hastal\u0131\u011f\u0131n prostat d\u0131\u015f\u0131nda ba\u015fka dokularda ve organlarda da saptanmas\u0131 anlam\u0131na gelen metastatik yay\u0131lmaya da dikkat \u00e7ekiliyor. Metastatik kanserin tan\u0131 an\u0131nda hem hasta hem de hekim a\u00e7\u0131s\u0131ndan can s\u0131k\u0131c\u0131 bir durum oldu\u011funun alt\u0131n\u0131 \u00e7izen Ataus, \u201cHastalar\u0131n y\u00fczde 8,9\u2019unda tan\u0131 an\u0131nda metastatik hastal\u0131k saptan\u0131rken, bu oran 2009 y\u0131l\u0131nda yine derne\u011fimiz taraf\u0131ndan ger\u00e7ekle\u015ftirilen \u00e7al\u0131\u015fmada y\u00fczde 17 olarak saptanm\u0131\u015ft\u0131. Aradan ge\u00e7en 10 y\u0131lda yakla\u015f\u0131k yar\u0131 yar\u0131ya azalman\u0131n s\u00f6z konusu oldu\u011funu g\u00f6rmek sevindiricidir\u201d ifadelerini kulland\u0131.<\/p>\n
Son 10 y\u0131lda erken te\u015fhiste \u00f6nemli ilerlemeler ya\u015fand\u0131<\/p>\n
PSA (Prostat Spesifik Antijen) taramas\u0131, \u00f6zellikle metastatik hastal\u0131k (yayg\u0131n-sistemik hastal\u0131k) g\u00f6r\u00fclme oranlar\u0131nda d\u00fc\u015f\u00fc\u015fe neden olan fakt\u00f6rler aras\u0131nda g\u00f6steriliyor. Rapora g\u00f6re hastalar\u0131n y\u00fczde 62,5\u2019inde tan\u0131 an\u0131nda \u00f6l\u00e7\u00fclen PSA de\u011feri 10 ng\/dl\u2019nin alt\u0131nda saptan\u0131yor. Bu oran\u0131n 2009 y\u0131l\u0131nda yine \u00dcroonkoloji Derne\u011fi taraf\u0131nda ger\u00e7ekle\u015ftirilen bir \u00e7al\u0131\u015fmada y\u00fczde 50,6 olarak saptand\u0131\u011f\u0131n\u0131 hat\u0131rlatan Y\u00f6netim Kurulu \u00dcyesi Prof. Dr. Sinan S\u00f6zen, \u201cSon 10 y\u0131lda prostat kanseri \u00e7ok daha d\u00fc\u015f\u00fck PSA de\u011ferlerinde yakalan\u0131yor ve erken te\u015fhiste b\u00fcy\u00fck ilerlemeler ya\u015fan\u0131yor. Bununla birlikte PSA testinin tek ba\u015f\u0131na yeterli olmad\u0131\u011f\u0131 ve mutlaka \u00fcroloji uzman\u0131 taraf\u0131ndan yap\u0131lacak prostat muayenesi ile birlikte de\u011ferlendirilmesi gerekti\u011fini de unutmamam\u0131z gerekiyor\u201d dedi.<\/p>\n
S\u00f6zen, \u201c\u00d6zel prostat MR\u2019\u0131nda prostat bezinde kanser i\u00e7in \u015f\u00fcpheli bir alan olup olmad\u0131\u011f\u0131 de\u011ferlendiriliyor. Kanser \u015f\u00fcphesi saptanan b\u00f6l\u00fcmler i\u015faretlenip daha sonra \u00f6zel bir yaz\u0131l\u0131m sayesinde ultrasona yerle\u015ftiriliyor. Biyopsi yaparken MR ve ultrason g\u00f6r\u00fcnt\u00fclerinin birle\u015fmi\u015f halini g\u00f6r\u00fcp do\u011fru noktadan, do\u011fru hedeften biyopsi yapabilmek m\u00fcmk\u00fcn oluyor\u201d dedi.<\/p>\n
Hastalar\u0131n y\u00fczde 6\u2019ya yak\u0131n\u0131nda tan\u0131 sonras\u0131 aktif izlem karar\u0131 al\u0131n\u0131yor<\/p>\n
Prostat kanseri tan\u0131s\u0131nda son on y\u0131lda ya\u015fanan en \u00f6nemli de\u011fi\u015fiklerden biri olarak hastal\u0131\u011f\u0131n ilerlemesi a\u00e7\u0131s\u0131ndan d\u00fc\u015f\u00fck risk grubundaki hastalara yap\u0131lan-\u00f6nerilen \u201cAktif \u0130zlem\u201d tedavi protokol\u00fc g\u00f6steriliyor. Y\u00f6netim Kurulu \u00dcyesi Prof. Dr. Saadettin Eski\u00e7orap\u00e7\u0131, \u201cHastaya zarar verme riski d\u00fc\u015f\u00fck olan hastal\u0131\u011f\u0131n tedavisinin yol a\u00e7abilece\u011fi olas\u0131 komplikasyonlardan sak\u0131nmay\u0131 sa\u011flayan aktif izlem protokol\u00fcnde hastalar yak\u0131n bir takip program\u0131nda tutulurken, aktif tedaviye ilerleme g\u00f6r\u00fclen olgularda ge\u00e7iliyor\u201d ifadelerini kulland\u0131. T\u00fcrkiye\u2019de Prostat Kanseri Raporuna g\u00f6re hastalar\u0131n y\u00fczde 5,7\u2019sinde tan\u0131 sonras\u0131 aktif izlem ile takip karar\u0131 al\u0131nd\u0131\u011f\u0131 belirtiliyor.<\/p>\n
Robotik ve fokal tedaviler y\u00fckseli\u015fte<\/p>\n
Lokalize hastal\u0131kta d\u00fcnya genelinde en \u00e7ok ba\u015fvurulan tedavi y\u00f6nteminin ise cerrahi oldu\u011fu vurgulan\u0131yor. \u201cRadikal Prostatektomi\u201d ameliyat\u0131 sadece ABD\u2019de y\u0131lda 80 bin hastaya uygulan\u0131rken bu cerrahi teknikle ilgili olarak son y\u0131llardaki en \u00f6nemli geli\u015fmenin robot yard\u0131m\u0131yla ger\u00e7ekle\u015ftirilen laparoskopik cerrahi y\u00f6ntemi oldu\u011fu vurgulan\u0131yor. Eski\u00e7orap\u00e7\u0131, \u201cRadikal prostatektomi ameliyat\u0131 uygulanan hastalar\u0131n yakla\u015f\u0131k 3\u2019te 1\u2019inde laparoskopik veya robot yard\u0131m\u0131yla laparoskopik cerrahi y\u00f6ntemi uygulan\u0131yor. Seneler i\u00e7erisindeki da\u011f\u0131l\u0131ma bak\u0131ld\u0131\u011f\u0131nda ise, a\u00e7\u0131k cerrahi say\u0131lar\u0131n\u0131n sabit seyretti\u011fi ancak laparoskopik ya da robot yard\u0131m\u0131yla laparoskopik cerrahi say\u0131lar\u0131nda ise bir art\u0131\u015f\u0131n oldu\u011fu g\u00f6r\u00fcl\u00fcyor. Hastalar\u0131n tedavileri i\u00e7in bir teknik aray\u0131\u015f\u0131 i\u00e7inde olmalar\u0131 yerine tecr\u00fcbeli ve g\u00fcvenilir bir cerrah aray\u0131\u015f\u0131 i\u00e7inde olmalar\u0131 faydal\u0131d\u0131r. T\u00fcm organ\u0131 tedavi etmek yerine g\u00f6r\u00fcnt\u00fclemeye dayal\u0131 hedefe y\u00f6nelik \u2018Fokal Tedaviler\u2019 ise yak\u0131n gelecekte \u00f6n plana \u00e7\u0131kmaya ba\u015flayacakt\u0131r\u201d dedi.<\/p>\n","protected":false},"excerpt":{"rendered":"
PROF. DR SAADETT\u0130N ESK\u0130\u00c7ORAP\u00c7I<\/p>\n","protected":false},"author":1,"featured_media":1553470,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,20],"tags":[30666,26192,13004,5210,12751,17272,12658,12653],"class_list":["post-1553469","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","category-turkiye","tag-erkeklerde","tag-gorulen","tag-ikinci","tag-kanser","tag-kanseri","tag-prostat","tag-sik","tag-turu"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1553469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1553469"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1553469\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/media\/1553470"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1553469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1553469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1553469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}